Renal Cancers Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

DBCOND0044624 (Renal Cancers)Terminated2 IdentifierTitlePurposeDrugs
NCT01264341Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell CarcinomaTreatment
NCT00601926Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney CancerTreatment